Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$152.69
-0.7%		$140.30
$108.35
▼
$163.75
$43.12B1.252.24 million shs634,617 shs
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$260.27
-0.6%		$222.14
$154.50
▼
$265.25
$42.84B1.181.74 million shs339,545 shs
Waters Corporation stock logo
WAT
Waters
$412.80
-0.5%		$387.53
$282.77
▼
$426.22
$40.56B1.19998,678 shs227,066 shs
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
$24.40
-4.5%		$21.77
$12.45
▼
$27.00
$11.96BN/A2,252 shs1,182 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.00%-3.00%+11.68%+13.51%+22.95%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
0.00%+0.12%+10.80%+39.19%+36.59%
Waters Corporation stock logo
WAT
Waters
0.00%+0.53%+9.74%+9.97%+37.32%
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
0.00%-2.34%+27.75%+53.41%+85.48%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$152.69
-0.7%		$140.30
$108.35
▼
$163.75
$43.12B1.252.24 million shs634,617 shs
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$260.27
-0.6%		$222.14
$154.50
▼
$265.25
$42.84B1.181.74 million shs339,545 shs
Waters Corporation stock logo
WAT
Waters
$412.80
-0.5%		$387.53
$282.77
▼
$426.22
$40.56B1.19998,678 shs227,066 shs
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
$24.40
-4.5%		$21.77
$12.45
▼
$27.00
$11.96BN/A2,252 shs1,182 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.00%-3.00%+11.68%+13.51%+22.95%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
0.00%+0.12%+10.80%+39.19%+36.59%
Waters Corporation stock logo
WAT
Waters
0.00%+0.53%+9.74%+9.97%+37.32%
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
0.00%-2.34%+27.75%+53.41%+85.48%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.85
Moderate Buy$170.3311.56% Upside
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2.88
Moderate Buy$241.88-7.06% Downside
Waters Corporation stock logo
WAT
Waters
2.80
Moderate Buy$424.352.80% Upside
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
3.50
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest WUXAY, A, IQV, and WAT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2026
Waters Corporation stock logo
WAT
Waters
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutral ➝ Overweight$400.00 ➝ $480.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$155.00 ➝ $175.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$185.00 ➝ $190.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$155.00 ➝ $180.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$170.00 ➝ $180.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$150.00 ➝ $175.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$180.00 ➝ $190.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$155.00 ➝ $180.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Sanford C. Bernstein logo
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$155.00 ➝ $180.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$155.00 ➝ $185.00
8/12/2026
Waters Corporation stock logo
WAT
Waters
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C) ➝ Hold (C-)
(Data available from 8/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.95B6.21$6.58 per share23.20$23.78 per share6.42
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$16.31B2.63$17.77 per share14.65$38.93 per share6.69
Waters Corporation stock logo
WAT
Waters
$4.64B8.73$16.55 per share24.94$43.01 per share9.60
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.30B$5.0830.0622.552.3419.53%24.45%13.09%N/A
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$1.36B$8.0632.2920.182.248.10%30.25%6.54%11/3/2026 (Estimated)
Waters Corporation stock logo
WAT
Waters
$642.63M$4.01102.9425.022.413.58%11.27%6.73%11/3/2026 (Estimated)
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
N/AN/AN/A20.33N/AN/AN/AN/A8/31/2026 (Estimated)

Latest WUXAY, A, IQV, and WAT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/31/2026N/A
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
$0.2321$0.3228+$0.0907N/A$1.91 billion$2.44 billion
8/26/2026Q3 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.49$1.62+$0.13$1.28$1.84 billion$1.88 billion
8/4/2026Q2 2026
Waters Corporation stock logo
WAT
Waters
$3.01$3.05+$0.04-$1.39$1.62 billion$1.65 billion
7/28/2026Q2 2026
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$3.03$3.15+$0.12$1.53$4.30 billion$4.37 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.020.67%+6.58%20.08%9 Years
IQVIA Holdings Inc. stock logo
IQV
IQVIA
N/AN/AN/AN/AN/A
Waters Corporation stock logo
WAT
Waters
N/AN/AN/AN/AN/A
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
$0.210.86%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.50
2.05
1.56
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2.18
0.71
0.71
Waters Corporation stock logo
WAT
Waters
0.32
1.86
1.29
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
IQVIA Holdings Inc. stock logo
IQV
IQVIA
89.62%
Waters Corporation stock logo
WAT
Waters
94.01%
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
N/A

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
IQVIA Holdings Inc. stock logo
IQV
IQVIA
1.70%
Waters Corporation stock logo
WAT
Waters
0.31%
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
18,100282.43 millionN/AOptionable
IQVIA Holdings Inc. stock logo
IQV
IQVIA
93,000164.60 million161.80 millionOptionable
Waters Corporation stock logo
WAT
Waters
7,90098.25 million97.94 millionOptionable
WuXi AppTec Co., Ltd. stock logo
WUXAY
WuXi AppTec
41,116490.33 millionN/ANot Optionable

Recent News About These Companies

WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion
August 30 at 9:00 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/wuxi-apptec-continues-to-reward-shareholders-further-increasing-interim-dividend-to-rmb-1-51-billion-302864374.html
Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) Is a Great Choice for 'Trend' Investors, Here's Why
August 27, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2980831/wuxi-apptec-co-ltd-sponsored-adr-wuxay-is-a-great-choice-for-trend-investors-here-s-why?cid=cs-stocknewsapi-ft-fundamental_analysis|recent_price_strength_screen-2980831
WuXi AppTec Wins Court Block on US Military-Company Designation
August 15, 2026  |  law.comL
Here's Why Momentum in Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) Should Keep going
August 11, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2972549/here-s-why-momentum-in-wuxi-apptec-co-ltd-sponsored-adr-wuxay-should-keep-going?cid=cs-stocknewsapi-ft-fundamental_analysis|recent_price_strength_screen-2972549
WuXi AppTec’s Integrated CRDMO Model Shortens Discovery-to-IND Timelines for Biotechnology Partners
August 4, 2026  |  oklahoman.comO
WuXi AppTec’ s Support for Small and Emerging Biotech Companies: Three Global Examples
August 4, 2026  |  azcentral.comA
WuXi AppTec Sees Pentagon Tag Hurting Reputation, US Business
August 3, 2026  |  bloomberg.comhttps://www.bloomberg.com/news/articles/2026-08-03/wuxi-apptec-sees-pentagon-tag-hurting-reputation-us-business
Chinese biotech giant Wuxi AppTec sees first-half earnings surge amid US scrutiny
August 3, 2026  |  msn.comhttps://www.msn.com/en-xl/money/other/chinese-biotech-giant-wuxi-apptec-sees-first-half-earnings-surge-amid-us-scrutiny/ar-AA29j5Tw
Wall Street funds back China’s WuXi AppTec as weight-loss drug orders soar
July 24, 2026  |  msn.comhttps://www.msn.com/en-xl/money/other/wall-street-funds-back-china-s-wuxi-apptec-as-weight-loss-drug-orders-soar/ar-AA28zL2m
WuXi AppTec’s CRDMO Model: Linking Research, Development, and Manufacturing Across the Drug Development Lifecycle
May 1, 2026  |  tennessean.comT
WuXi AppTec Shares Rise After Strong Annual Results
March 24, 2026  |  marketwatch.comhttps://www.marketwatch.com/story/wuxi-apptec-shares-rise-after-strong-annual-results-ecf21814
WuXi AppTec Co., Ltd. (WUXAY) Q4 2025 Earnings Call Transcript
March 24, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4885165-wuxi-apptec-co-ltd-wuxay-q4-2025-earnings-call-transcript
WuXi AppTec Receives Double "A" Rating from CDP for Climate Change and Water Security Leadership
January 18, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/wuxi-apptec-receives-double-a-rating-from-cdp-for-climate-change-and-water-security-leadership-302664053.html
JPM26: WuXi AppTec drives growth through late-stage pipeline and record backlog
January 15, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/jpm26-wuxi-apptec-drives-growth-221800778.html
WuXi AppTec Co., Ltd. (WUXAY) Presents at 44th Annual J.P.
January 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4859760-wuxi-apptec-co-ltd-wuxay-presents-at-44th-annual-j-p-morgan-healthcare-conference-transcript
WuXi AppTec Issues Positive Profit Alert for the Full Year of 2025
January 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/wuxi-apptec-issues-positive-profit-093000020.html
After dodging Biosecure threat, WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg
December 4, 2025  |  fiercepharma.comF
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry
November 19, 2025  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2025/11/19/10293994.htm
European firms raise two big funds for early biotech
November 17, 2025  |  statnews.comS
China’s WuXi AppTec, after evading threat of U.S. restrictions, comes out ahead
November 17, 2025  |  statnews.comS

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
A quantum computing processor glows inside a gold-plated dilution refrigerator in a research laboratory.
The Quantum Race Is Heating Up—And 2 Small Players Stand Out
By Nathan Reiff | August 17, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
The Metals Company logo displayed over an image of polymetallic nodules on the seafloor with sea stars.
The Metals Company’s Big Bet Now Comes Down to a License
By Thomas Hughes | August 16, 2026
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$152.69 -1.15 (-0.75%)
As of 02:17 PM Eastern

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

IQVIA stock logo

IQVIA NYSE:IQV

$260.27 -1.48 (-0.57%)
As of 02:17 PM Eastern

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Waters stock logo

Waters NYSE:WAT

$412.80 -1.89 (-0.46%)
As of 02:16 PM Eastern

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

WuXi AppTec stock logo

WuXi AppTec OTCMKTS:WUXAY

$24.40 -1.16 (-4.53%)
As of 12:23 PM Eastern

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas